Management of Euglycemic Diabetic Ketoacidosis

被引：0
|
作者：
Mathew, Daniya S. [1 ]
Ng, Kimberly E. [2 ]
Jacob, Elsen C. [2 ]
机构：
[1] St Johns Univ, Coll Pharm & Hlth Sci, New York, NY 11439 USA
[2] St Johns Univ, Coll Pharm & Hlth Sci, Dept Clin Hlth Profess, New York, NY USA
来源：
US PHARMACIST | 2021年 / 46卷 / 11期
关键词：
INHIBITORS;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Euglycemic diabetic ketoacidosis (EDKA) is a rare, acute, life-threatening emergency that is characterized by euglycemia, metabolic acidosis, and ketoacidosis. Unlike DKA, the diagnosis of EDKA is often overlooked because of the absence of hyperglycemia. The mechanism behind EDKA involves a general state of starvation that results in ketosis while normoglycemia is maintained. EDKA may be associated with precipitating factors, including sodium-glucose cotransporter 2 inhibitors, starvation, pregnancy, alcohol use, surgery, and drug-induced intoxication. A stepwise approach is used in the management of EDKA. Pharmacists can assist the medical team in preventing EDKA and can play a role in the management of EDKA.
引用
收藏
页码：HS1 / HS6
页数：6
相关论文
共 50 条
  • [41] CHALLENGES IN THE DIAGNOSIS OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH MULTIPLE SCLEROSIS TAKING A SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR
    Allison, Robert
    Goldstein, Daniel
    Musso, Mandi W.
    JOURNAL OF EMERGENCY MEDICINE, 2019, 57 (01): : E1 - E3
  • [42] Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports
    Juneja, Deven
    Nasa, Prashant
    Jain, Ravi
    Singh, Omender
    WORLD JOURNAL OF DIABETES, 2023, 14 (08) : 1314 - 1322
  • [43] Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus
    Banakh, Iouri
    Kung, Ross
    Gupta, Sachin
    Matthiesson, Kati
    Tiruvoipati, Ravindranath
    CLINICAL CASE REPORTS, 2019, 7 (05): : 1087 - 1090
  • [44] Pathogenesis of euglycemic ketoacidosis associated with SGLT2 inhibitors
    Sitina, M.
    Sramek, V
    ANESTEZIOLOGIE A INTENZIVNI MEDICINA, 2024, 35 (02): : 98 - 103
  • [45] Postoperative Euglycemic Diabetic Ketoacidosis and Encephalopathy Related to SGLT-2 Inhibitors: A Case Report and Discussion of Diabetes Treatment and "Sweet Pee Encephalopathy" in Perioperative Hospital Management
    Mackintosh, Christopher
    Tewari, Arti
    Siegel, Jason
    Wang, R. Doris
    Freeman, William
    NEUROHOSPITALIST, 2020, 10 (01): : 51 - 54
  • [46] "The Bitter Truth of Sugar"-Euglycemic Diabetic Ketoacidosis due to Sodium-glucose Cotransporter-2 Inhibitors: A Case Series
    Shah, Mehul
    Pathrose, Edwin
    Bhagwat, Nikhil M.
    Chandy, David
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 26 (01) : 123 - 126
  • [47] Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers
    Somagutta, Manoj R.
    Agadi, Kuchalambal
    Hange, Namrata
    Jain, Molly S.
    Batti, Erkan
    Emuze, Bernard O.
    Amos-Arowoshegbe, Elizabeth O.
    Popescu, Sorin
    Hanan, Saad
    Kumar, Varadha Retna
    Pormento, Kezia
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (03)
  • [48] Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature
    Diaz-Ramos, Alexis
    Eilbert, Wesley
    Marquez, Diego
    INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE, 2019, 12 (01)
  • [49] Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report
    VonTungeln, Christopher D.
    Al Bataineh, Mohammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [50] Recurrent diabetic ketoacidosis
    Brandstaetter, Evgenia
    Bartal, Carmi
    Sagy, Iftach
    Jotkowitz, Alan
    Barski, Leonid
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2019, 63 (05): : 531 - 535
12345